VVT Med, Inc. (VVTM.V)
0.20
0.00 (0.00%)
CAD |
TSXV |
Oct 09, 16:00
VVT Med Net Income (Quarterly) : -0.7725M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7725M |
| March 31, 2026 | -0.764M |
| December 31, 2025 | -1.070M |
| September 30, 2025 | -3.066M |
| June 30, 2025 | -0.637M |
| March 31, 2025 | -0.7504M |
| December 31, 2024 | -0.044M |
| September 30, 2024 | -0.039M |
| June 30, 2024 | -0.037M |
| March 31, 2024 | -0.036M |
| December 31, 2023 | -0.055M |
| September 30, 2023 | -0.061M |
| June 30, 2023 | -0.031M |
| March 31, 2023 | -0.032M |
| December 31, 2022 | -0.021M |
| September 30, 2022 | -0.03M |
| June 30, 2022 | -0.042M |
| March 31, 2022 | -0.043M |
| December 31, 2021 | -0.047M |
| September 30, 2021 | -0.059M |
| June 30, 2021 | -0.056M |
| March 31, 2021 | -0.082M |
| December 31, 2020 | -6.969M |
| September 30, 2020 | 0.047M |
| June 30, 2020 | 4.49M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.832M |
| December 31, 2019 | -2.972M |
| September 30, 2019 | -0.345M |
| June 30, 2019 | -0.434M |
| March 31, 2019 | -0.872M |
| December 31, 2018 | -8.739M |
| September 30, 2018 | -0.625M |
| June 30, 2018 | -1.086M |
| March 31, 2018 | -1.182M |
| December 31, 2017 | -1.285M |
| September 30, 2017 | -0.753M |
| June 30, 2017 | -1.621M |
| March 31, 2017 | -1.55M |
| December 31, 2016 | -2.366M |
| September 30, 2016 | -0.957M |
| June 30, 2016 | -0.564M |
| March 31, 2016 | -1.599M |
| December 31, 2015 | -3.827M |
| September 30, 2015 | -1.608M |
| June 30, 2015 | -0.503M |
| March 31, 2015 | -1.169M |
| December 31, 2014 | -3.331M |
| September 30, 2014 | -1.62M |
| June 30, 2014 | 0.73M |
| March 31, 2014 | -2.982M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| MedMira, Inc. | -0.4837M |
| MedX Health Corp. | -1.602M |
| VentriPoint Diagnostics Ltd. | -0.1998M |
| Theralase Technologies, Inc. | -1.062M |
| Profound Medical Corp. | -13.21M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0457M |
| Total Expenses (Quarterly) | 0.8182M |
| EPS Diluted (Quarterly) | -0.0108 |
| Enterprise Value | 16.16M |
| Gross Profit Margin (Quarterly) | 45.51% |
| Profit Margin (Quarterly) | -1.69K% |
| Earnings Yield | -42.20% |
| Normalized Earnings Yield | -39.10 |